{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:45:28Z","timestamp":1768427128625,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1124\/jpet.120.000285","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T20:52:23Z","timestamp":1605646343000},"page":"190-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy"],"prefix":"10.1016","volume":"376","author":[{"given":"Tamara R.","family":"Casta\u00f1eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Elvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Schwahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Boldina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh S.","family":"Bangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechthilde","family":"Falkenhahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimo","family":"Kannt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Konkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Arbeeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep K.","family":"Dhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5121-0022","authenticated-orcid":false,"given":"Thomas","family":"H\u00fcbschle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000285_bib1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.120.000285_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1124\/jpet.120.000285_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/JOE-11-0122","article-title":"Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats","volume":"210","author":"Bilan","year":"2011","journal-title":"J Endocrinol"},{"issue":"Suppl 2","key":"10.1124\/jpet.120.000285_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1464-5491.2008.02496.x","article-title":"Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?","volume":"25","author":"Bilous","year":"2008","journal-title":"Diabet Med"},{"key":"10.1124\/jpet.120.000285_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000285_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1523-1755.2002.00459.x","article-title":"Bile acid binding to sevelamer HCl","volume":"62","author":"Braunlin","year":"2002","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000285_bib11","doi-asserted-by":"crossref","first-page":"107446","DOI":"10.1016\/j.jdiacomp.2019.107446","article-title":"Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the BAS sevelamer: two randomised, placebo-controlled trials","volume":"34","author":"Br\u00f8nden","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1124\/jpet.120.000285_bib12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/dom.13272","article-title":"Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer","volume":"20","author":"Br\u00f8nden","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.120.000285_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/00912700122009872","article-title":"Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics","volume":"41","author":"Burke","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.120.000285_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2215\/CJN.02810707","article-title":"Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients","volume":"3","author":"Caglar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 10","key":"10.1124\/jpet.120.000285_bib15","first-page":"S75","article-title":"The discovery of diabetic nephropathy: from small print to centre stage","volume":"19","author":"Cameron","year":"2006","journal-title":"J Nephrol"},{"key":"10.1124\/jpet.120.000285_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00592-018-1220-1","article-title":"Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats","volume":"56","author":"Castoldi","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1124\/jpet.120.000285_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1515\/CCLM.2006.050","article-title":"Urinary cystatin C as a specific marker of tubular dysfunction","volume":"44","author":"Conti","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1124\/jpet.120.000285_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.120.000285_bib21","doi-asserted-by":"crossref","first-page":"e0181861","DOI":"10.1371\/journal.pone.0181861","article-title":"High resolution molecular and histological analysis of renal disease progression in ZSF1 fa\/faCP rats, a model of type 2 diabetic nephropathy","volume":"12","author":"Dower","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000285_bib22","first-page":"85","article-title":"Some bioenergetic parameters of wild ruminants","volume":"1","author":"Drozdz","year":"1975","journal-title":"Pol Ecol Stud"},{"key":"10.1124\/jpet.120.000285_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S000711450000177X","article-title":"Soluble polysaccharide and biomass of red microalga Porphyridium sp. alter intestinal morphology and reduce serum cholesterol in rats","volume":"84","author":"Dvir","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1124\/jpet.120.000285_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/dom.12030","article-title":"Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight","volume":"15","author":"Elvert","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.120.000285_bib25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ekir.2019.07.009","article-title":"Pilot study of renal urinary biomarkers for diagnosis of CKD of uncertain etiology","volume":"4","author":"Fernando","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1124\/jpet.120.000285_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40620-016-0266-9","article-title":"Phosphate binders in chronic kidney disease: a systematic review of recent data","volume":"29","author":"Floege","year":"2016","journal-title":"J Nephrol"},{"issue":"Suppl 5","key":"10.1124\/jpet.120.000285_bib27","doi-asserted-by":"crossref","first-page":"V59","DOI":"10.1093\/ndt\/gfh1058","article-title":"Vascular calcification in patients with end-stage renal disease","volume":"19","author":"Floege","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.120.000285_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40256-019-00393-x","article-title":"Effects of blood pressure lowering agents on cardiovascular outcomes in weight excess patients: a systematic review and meta-analysis","volume":"20","author":"Francischetti","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1124\/jpet.120.000285_bib29","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/gutjnl-2017-314553","article-title":"Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-\/- mice by modulating composition, signalling and excretion of faecal bile acids","volume":"67","author":"Fuchs","year":"2018","journal-title":"Gut"},{"key":"10.1124\/jpet.120.000285_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.120.000285_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00592-018-1142-y","article-title":"Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes","volume":"55","author":"Giorda","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1124\/jpet.120.000285_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000285_bib33","doi-asserted-by":"crossref","first-page":"F1605","DOI":"10.1152\/ajprenal.00511.2006","article-title":"Dynamic blood pressure load and nephropathy in the ZSF1 (fa\/fa cp) model of type 2 diabetes","volume":"293","author":"Griffin","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 2","key":"10.1124\/jpet.120.000285_bib34","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc11-s237","article-title":"Role of bile acid sequestrants in the treatment of type 2 diabetes","volume":"34","author":"Handelsman","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.120.000285_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11892-014-0482-4","article-title":"Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes","volume":"14","author":"Hansen","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1124\/jpet.120.000285_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/marc.1984.030050104","article-title":"Homopolymerization of monoallylammonium salts with azo-initiators","volume":"5","author":"Harada","year":"1984","journal-title":"Macromol Chem Rapid Commun"},{"key":"10.1124\/jpet.120.000285_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.clinbiochem.2007.04.013","article-title":"Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate","volume":"40","author":"Herget-Rosenthal","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1124\/jpet.120.000285_bib38","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.23408","article-title":"Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice","volume":"51","author":"Herrema","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/jpet.120.000285_bib39","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000285_bib40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/0192623318803278","article-title":"41-Week study of progressive diabetic nephropathy in the ZSF1 fa\/fa CP rat model","volume":"46","author":"Homer","year":"2018","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.120.000285_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/bioinformatics\/bts294","article-title":"OSA: a fast and accurate alignment tool for RNA-Seq","volume":"28","author":"Hu","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1124\/jpet.120.000285_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrneph.2011.112","article-title":"Pharmacology, efficacy and safety of oral phosphate binders","volume":"7","author":"Hutchison","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.120.000285_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.120.000285_bib45","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/(SICI)1099-0518(199810)36:14<2619::AID-POLA22>3.0.CO;2-K","article-title":"Synthesis of polyamines with pendant cyanoimidazole units and their electrochemical properties","volume":"36","author":"Jang","year":"1998","journal-title":"J Polym Sci A Polym Chem"},{"key":"10.1124\/jpet.120.000285_bib46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/jch.13325","article-title":"Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: an \u201cold dog playing good tricks\u201d","volume":"20","author":"Katsiki","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1124\/jpet.120.000285_bib47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2337\/dc12-0849","article-title":"Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.120.000285_bib48","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.120.000285_bib49","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1124\/jpet.120.000285_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1210\/endrev\/bnz010","article-title":"The new biology of diabetic kidney disease-mechanisms and therapeutic implications","volume":"41","author":"Lytvyn","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.120.000285_bib51","doi-asserted-by":"crossref","first-page":"e24564","DOI":"10.1371\/journal.pone.0024564","article-title":"Bile acid sequestration reduces plasma glucose levels in db\/db mice by increasing its metabolic clearance rate","volume":"6","author":"Meissner","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000285_bib52","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res"},{"key":"10.1124\/jpet.120.000285_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1472-8206.2012.01048.x","article-title":"Comparative study between atorvastatin and losartan on high fat diet-induced type 2 diabetes mellitus in rats","volume":"27","author":"Mourad","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.120.000285_bib54","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.2215\/CJN.01650211","article-title":"Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients","volume":"6","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/17460441.2018.1538206","article-title":"Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes","volume":"13","author":"Nerild","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/jpet.120.000285_bib56","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ki.2010.554","article-title":"Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy","volume":"79","author":"Nielsen","year":"2011","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00079-19","article-title":"Comparative performance of urinary biomarkers for vancomycin-induced kidney injury according to timeline of injury","volume":"63","author":"Pais","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.120.000285_bib58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-020-00997-7","article-title":"Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat","volume":"19","author":"Park","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1124\/jpet.120.000285_bib59","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials","volume":"11","author":"Patel","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib60","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/10601325.2012.728460","article-title":"Hydrophobically modified poly(Allylamine) hydrogels containing internal quaternary ammonium groups as cholesterol lowering agents: synthesis, characterization, and biological studies","volume":"49","author":"Polomoscanik","year":"2012","journal-title":"J Macromol Sci A"},{"key":"10.1124\/jpet.120.000285_bib61","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00400.2012","article-title":"Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice","volume":"304","author":"Potthoff","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000285_bib62","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.exger.2007.05.008","article-title":"Metabolizable energy intake during long-term calorie restriction in rhesus monkeys","volume":"42","author":"Raman","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1124\/jpet.120.000285_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1753944713513061","article-title":"Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease","volume":"7","author":"Rastogi","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1124\/jpet.120.000285_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nefro.2015.05.022","article-title":"Use of sevelamer in chronic kidney disease: beyond phosphorus control","volume":"35","author":"Rodr\u00edguez-Osorio","year":"2015","journal-title":"Nefrologia"},{"key":"10.1124\/jpet.120.000285_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/js9603820","article-title":"Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration","volume":"86","author":"Rosenbaum","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000285_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4158\/EP10130.OR","article-title":"Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes","volume":"16","author":"Rosenstock","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1124\/jpet.120.000285_bib67","doi-asserted-by":"crossref","first-page":"G810","DOI":"10.1152\/ajpgi.00238.2018","article-title":"Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes","volume":"315","author":"Sedgeman","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000285_bib68","doi-asserted-by":"crossref","first-page":"G815","DOI":"10.1152\/ajpgi.00295.2011","article-title":"The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model","volume":"302","author":"Shang","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.120.000285_bib69","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3945\/ajcn.2008.26752","article-title":"Comparison of self-reported, measured, metabolizable energy intake with total energy expenditure in overweight teens","volume":"89","author":"Singh","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/jpet.120.000285_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1527-3466.2005.tb00154.x","article-title":"Colesevelam: potential uses for the newest bile resin","volume":"23","author":"Steinmetz","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/jpet.120.000285_bib71","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/kisup.2013.96","article-title":"Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients","volume":"3","author":"Streja","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1124\/jpet.120.000285_bib72","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/labinvest.2010.107","article-title":"Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice","volume":"90","author":"Stroeve","year":"2010","journal-title":"Lab Invest"},{"key":"10.1124\/jpet.120.000285_bib73","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000449324","article-title":"Longitudinal changes in measured glomerular filtration rate, renal fibrosis and biomarkers in a rat model of type 2 diabetic nephropathy","volume":"44","author":"Su","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1124\/jpet.120.000285_bib74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/jbcpp-2017-0157","article-title":"Losartan improves renal function and pathology in obese ZSF-1 rats","volume":"29","author":"Su","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1124\/jpet.120.000285_bib75","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2009.403","article-title":"Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism","volume":"114","author":"Sun","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/jpet.120.000285_bib76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jpba.2004.02.021","article-title":"Determination of the binding parameter constants of Renagel capsules and tablets at pH 7 by high performance capillary electrophoresis","volume":"35","author":"Swearingen","year":"2004","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.120.000285_bib77","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4239\/wjd.v1.i5.146","article-title":"Role of bile acid sequestrants in the treatment of type 2 diabetes","volume":"1","author":"Takebayashi","year":"2010","journal-title":"World J Diabetes"},{"key":"10.1124\/jpet.120.000285_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11892-019-1133-6","article-title":"The global burden of diabetic kidney disease: time trends and gender gaps","volume":"19","author":"Thomas","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1124\/jpet.120.000285_bib79","series-title":"United States Renal Data System Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2015"},{"key":"10.1124\/jpet.120.000285_bib80","doi-asserted-by":"crossref","first-page":"e002760","DOI":"10.1161\/CIRCHEARTFAILURE.115.002760","article-title":"Distinct endothelial cell responses in the heart and kidney microvasculature characterize the progression of heart failure with preserved ejection fraction in the obese ZSF1 rat with cardiorenal metabolic syndrome","volume":"9","author":"van Dijk","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1124\/jpet.120.000285_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.120.000285_bib82","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2215\/CJN.12891211","article-title":"Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease","volume":"7","author":"Vlassara","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.120.000285_bib83","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ki.2012.210","article-title":"Losartan and enalapril are comparable in reducing proteinuria in children","volume":"82","author":"Webb","year":"2012","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.120.000285_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/hr.2015.155","article-title":"Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose","volume":"39","author":"Xiao","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1124\/jpet.120.000285_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:32:04Z","timestamp":1739964724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022356524257487"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000285","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}